Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis

NCT00049764 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

474

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Drotrecogin alfa (activated)
DRUG: Placebo

Sponsor

Eli Lilly and Company